CROI 2014: Advances in antiretroviral therapy

Barbara S. Taylor, Noga Shalev, Timothy J. Wilkin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Original languageEnglish
Pages (from-to)616-631
Number of pages16
JournalTopics in antiviral medicine
Volume22
Issue number2
StatePublished - 2014

Fingerprint

Retroviridae Infections
Opportunistic Infections
HIV
Mississippi
Therapeutics
Drug Resistance
HIV Infections
Economics
Mothers
Research Personnel
Delivery of Health Care

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Pharmacology
  • Virology

Cite this

Taylor, B. S., Shalev, N., & Wilkin, T. J. (2014). CROI 2014: Advances in antiretroviral therapy. Topics in antiviral medicine, 22(2), 616-631.

CROI 2014 : Advances in antiretroviral therapy. / Taylor, Barbara S.; Shalev, Noga; Wilkin, Timothy J.

In: Topics in antiviral medicine, Vol. 22, No. 2, 2014, p. 616-631.

Research output: Contribution to journalArticle

Taylor, BS, Shalev, N & Wilkin, TJ 2014, 'CROI 2014: Advances in antiretroviral therapy', Topics in antiviral medicine, vol. 22, no. 2, pp. 616-631.
Taylor, Barbara S. ; Shalev, Noga ; Wilkin, Timothy J. / CROI 2014 : Advances in antiretroviral therapy. In: Topics in antiviral medicine. 2014 ; Vol. 22, No. 2. pp. 616-631.
@article{4fd7df6589294a519a5cb242a5f40de8,
title = "CROI 2014: Advances in antiretroviral therapy",
abstract = "The 2014 Conference on Retroviruses and Opportunistic Infections (CROI) highlighted important advances in antiretroviral therapy, with an emphasis on HIV eradication strategies. Follow-up information about the Mississippi baby who remains free of HIV infection off antiretroviral therapy was presented, and a second baby and 1 adult may also have been cured with very early initiation of antiretroviral therapy. The HIV care cascade was again a major focus of the conference. Investigators from around the world presented data on the implementation, and limitations, of the care cascade paradigm. Scale-up of antiretroviral therapy continues and a number of presentations featured optimal ways to measure the impact of these efforts by applying lessons from implementation science and health care economics. Encouraging results from expanded prevention of mother-to-child transmission programs, especially Option B+, were highlighted. Extensive data on transmitted (primary) drug resistance in the United States and Europe were presented.",
keywords = "Cascade of care, CROI 2014, Cure, HIV, Resource limited, Treatment",
author = "Taylor, {Barbara S.} and Noga Shalev and Wilkin, {Timothy J.}",
year = "2014",
language = "English",
volume = "22",
pages = "616--631",
journal = "Topics in antiviral medicine",
issn = "2161-5853",
publisher = "International Antiviral Society",
number = "2",

}

TY - JOUR

T1 - CROI 2014

T2 - Advances in antiretroviral therapy

AU - Taylor, Barbara S.

AU - Shalev, Noga

AU - Wilkin, Timothy J.

PY - 2014

Y1 - 2014

N2 - The 2014 Conference on Retroviruses and Opportunistic Infections (CROI) highlighted important advances in antiretroviral therapy, with an emphasis on HIV eradication strategies. Follow-up information about the Mississippi baby who remains free of HIV infection off antiretroviral therapy was presented, and a second baby and 1 adult may also have been cured with very early initiation of antiretroviral therapy. The HIV care cascade was again a major focus of the conference. Investigators from around the world presented data on the implementation, and limitations, of the care cascade paradigm. Scale-up of antiretroviral therapy continues and a number of presentations featured optimal ways to measure the impact of these efforts by applying lessons from implementation science and health care economics. Encouraging results from expanded prevention of mother-to-child transmission programs, especially Option B+, were highlighted. Extensive data on transmitted (primary) drug resistance in the United States and Europe were presented.

AB - The 2014 Conference on Retroviruses and Opportunistic Infections (CROI) highlighted important advances in antiretroviral therapy, with an emphasis on HIV eradication strategies. Follow-up information about the Mississippi baby who remains free of HIV infection off antiretroviral therapy was presented, and a second baby and 1 adult may also have been cured with very early initiation of antiretroviral therapy. The HIV care cascade was again a major focus of the conference. Investigators from around the world presented data on the implementation, and limitations, of the care cascade paradigm. Scale-up of antiretroviral therapy continues and a number of presentations featured optimal ways to measure the impact of these efforts by applying lessons from implementation science and health care economics. Encouraging results from expanded prevention of mother-to-child transmission programs, especially Option B+, were highlighted. Extensive data on transmitted (primary) drug resistance in the United States and Europe were presented.

KW - Cascade of care

KW - CROI 2014

KW - Cure

KW - HIV

KW - Resource limited

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84906883507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906883507&partnerID=8YFLogxK

M3 - Article

C2 - 24901887

AN - SCOPUS:84906883507

VL - 22

SP - 616

EP - 631

JO - Topics in antiviral medicine

JF - Topics in antiviral medicine

SN - 2161-5853

IS - 2

ER -